Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.

BACKGROUND Cisplatin-based chemotherapy can cure more than 80% of metastatic germ-cell testicular tumors (GCTs). The response to cisplatin-based chemotherapy has been related to Microsatellite Instability (MSI), which is caused by genetic or epigenetic changes in genes of the DNA Mismatch Repair (MMR) pathway. PATIENTS AND METHODS We investigated 15 refractory and 36 chemosensitive GCTs for immunohistochemical loss of hMLH1, hMSH2 and hMSH6 protein expressions, in conjunction with hMLH1 gene methylation and MSI of GCTs, with a complete follow-up. RESULTS A loss of either of the MMR protein expressions was detected in 14 cases (27.5%). Pathological hMLH1 protein expression was seen in 10 cases (19.6%). hMLH1 methylation was found in 11 cases (21.60%) and was highly correlated with loss of hMLH1 expression (p < 0.0001) and with immunohistochemically-detected MMR deficiency (p = 0.0005). MSI was found in 16 cases (31.4%). There was no correlation between hMLH1 methylation and MSI. Neither hMLH1 methylation status, nor MSI correlated with any of the clinicopathological parameters investigated (tumor stage, histology, resistance to systemic treatment). CONCLUSION hMLH1 gene methylation was detected as a common alteration in GCTs, and correlated with the loss of hMLH1 protein expression (p < 0.0001). Neither hMLH1 gene methylation, MMR deficiency, nor MSI showed a relationship with the relevant clinicopathological parameters.

[1]  J. Bacik,et al.  Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors , 2004, Molecular Cancer.

[2]  P. Macpherson,et al.  DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells. , 2003, DNA repair.

[3]  C. Bokemeyer,et al.  Advances in Brief Microsatellite Instability of Germ Cell Tumors Is Associated with Resistance to Systemic Treatment 1 , 2002 .

[4]  J. Błasiak,et al.  Recognition and repair of DNA-cisplatin adducts. , 2002, Acta biochimica Polonica.

[5]  P. Laird,et al.  DNA methylation analysis by MethyLight technology. , 2001, Methods.

[6]  F. Berger,et al.  Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. , 2001, Molecular human reproduction.

[7]  P. Biron,et al.  Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors. , 2001, The Journal of urology.

[8]  D. Watson,et al.  Defects of DNA mismatch repair in human prostate cancer. , 2001, Cancer research.

[9]  P. Laird,et al.  Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .

[10]  I. Bodrogi,et al.  Three-Year Results of the First Educational and Early Detection Program for Testicular Cancer in Hungary , 2001, Oncology.

[11]  J. Herman,et al.  Promoter-region hypermethylation and gene silencing in human cancer. , 2000, Current topics in microbiology and immunology.

[12]  M. Dietel,et al.  Involvement of the DNA mismatch repair system in antineoplastic drug resistance , 1999, Journal of Cancer Research and Clinical Oncology.

[13]  N. Claij,et al.  Microsatellite instability in human cancer: a prognostic marker for chemotherapy? , 1999, Experimental cell research.

[14]  S. Leung,et al.  hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. , 1999, Cancer research.

[15]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[16]  R. Fishel,et al.  Interactions of Human hMSH2 with hMSH3 and hMSH2 with hMSH6: Examination of Mutations Found in Hereditary Nonpolyposis Colorectal Cancer , 1998, Molecular and Cellular Biology.

[17]  I. Bodrogi,et al.  Expression of bcl‐2 in testicular carcinoma , 1998, Cancer.

[18]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  I. Sesterhenn,et al.  Histological Typing of Testis Tumours , 1998, World Health Organization.

[20]  C. Macleod,et al.  In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. , 1997, Cancer research.

[21]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[22]  G. Marsischky,et al.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Lothe,et al.  Molecular genetic changes in human male germ cell tumors. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[24]  L. Aaltonen,et al.  Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. , 1993, Cancer research.

[25]  L. Einhorn.  Treatment of testicular cancer: a new and improved model. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  N. Javadpour.  The Role of Biologic Tumor Markers in Testicular Cancer , 1980, Cancer.